Mol Pharm. 2018 Mar 5;15(3):1341-1352. doi: 10.1021/acs.molpharmaceut.7b01142. Epub 2018 Feb 9.
The combination of multiple modalities has shown great potential in cancer treatment with improved therapeutic effects and minimized side effects. Here, we fabricated a type of doxorubicin-encapsulated biomimetic nanovesicle (NV) by a facile method with near-infrared dye insertion in the membrane for combinatorial photothermal and chemotherapy. With innate biomimetic properties, NVs enhanced the uptake by tumor cells while reducing the phagocytosis of macrophages. Upon laser irradiation, NVs can convert the absorbed fluorescent energy into heat for effective tumor killing. Hyperthermia can further induce membrane ablation of NVs to accelerate the release of chemotherapeutic drug for potent cytotoxicity to tumor cells. The NVs improved drug accumulation and showed a more efficient in vivo photothermal effect with a rapid temperature increase in tumors. Moreover, the NV-based combinational photothermal and chemotherapy exhibited significant tumor growth suppression with a high inhibitory rate of 91.6% and negligible systemic toxicity. The results indicate that NVs could be an appealing vehicle for combinational cancer treatment.
多种模式的联合在癌症治疗中显示出巨大的潜力,可提高治疗效果,同时将副作用降至最低。在这里,我们通过一种简便的方法制备了一种包载阿霉素的仿生纳米囊泡(NV),在膜中插入近红外染料用于联合光热和化疗。NV 具有内在的仿生特性,可增强肿瘤细胞的摄取,同时减少巨噬细胞的吞噬作用。激光照射后,NV 可将吸收的荧光能量转化为热量,从而有效杀死肿瘤。高热还可以进一步导致 NV 膜的消融,加速化疗药物的释放,对肿瘤细胞产生强烈的细胞毒性。NV 增加了药物的蓄积,并在体内显示出更有效的光热效应,肿瘤内的温度迅速升高。此外,基于 NV 的联合光热和化疗表现出显著的肿瘤生长抑制作用,抑制率高达 91.6%,且系统毒性可忽略不计。结果表明,NV 可以成为联合癌症治疗的一种有吸引力的载体。